EMA

  1. Showing 43 results for:
  2. EMA
All Subjects

Recommendation paper on decentralised elements in clinical trials

Published by EMA

Decentralised Clinical Trials

Recommendations that aim to facilitate the conduct of decentralised clinical trials (DCTs) while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected

View this resource Bookmark this resource

Guideline on computerised systems and electronic data in clinical trials

Published by EMA

Computerised systems, electronic data, validation, audit trail, user management, security, electronic clinical outcome assessment (eCOA), interactive response technology (IRT), case report form (CRF), electronic signatures, artificial intelligence (AI)

View this resource Bookmark this resource

Predictive biomarker-based assay development in the context of drug development and lifecycle

Published by EMA

EMAPredictive Biomarkers

The proposed concept paper is intended to be developed into a guideline which will replace the reflection paper on co-development of pharmacogenomic biomarkers and assays in the context of drug development. The guideline will provide recommendations on the interface between predictive biomarker-based assays including CDx, and the development and lifecycle of a medicine.

View this resource Bookmark this resource

Qualification of novel methodologies for drug development: guidance to applicants (EMA/CHMP/SAWP/72894/2008). 2013

Published by EMA

Scientific AdviceEMA Qualification

The EMA Qualification process is a new, voluntary, scientific pathway leading to either a CHMP Qualification opinion or a qualification advice on innovative methods or drug development tools

View this resource Bookmark this resource